In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Pocket Guidelines on Pulmonary Hypertension

ESC Pocket Guidelines

Congenital Heart Disease and Pediatric Cardiology
Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
Pulmonary Hypertension
Valvular Heart Disease
Chronic Heart Failure
Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure

Publication date: 2022

Chairpersons: Stephan Rosenkranz and Marion Delcroix 

Order Pocket Guidelines

Table of Contents

1. Introduction

2. Methods

3. Definitions and classifications

3.1. Definitions

3.2. Classifications

4. Epidemiology and risk factors

5. Pulmonary hypertension diagnosis

5.1. Diagnosis

5.2. Diagnostic algorithm

5.3. Screening and early detection

6. Pulmonary arterial hypertension (group

6.1. Clinical characteristics

6.2. Severity and risk assessment

6.3. Therapy

7. Specific pulmonary arterial hypertension subsets

7.1. Pulmonary arterial hypertension associated with drugs and toxins

7.2. Pulmonary arterial hypertension associated with connective tissue disease

7.3. Pulmonary arterial hypertension associated with human

immunodeficiency virus infection

7.4. Pulmonary arterial hypertension associated with portal hypertension

7.5. Pulmonary arterial hypertension associated with adult congenital

heart disease

7.6. Pulmonary arterial hypertension with signs of venous/capillaries


7.7. Paediatric pulmonary hypertension

8. Pulmonary hypertension associated with left heart disease (group 2)

8.1. Definition, prognosis, and pathophysiology

8.2. Diagnosis

8.3. Therapy

9. Pulmonary hypertension associated with lung diseases and/or hypoxia (group 3)

9.1. Diagnosis

9.2. Therapy

10. Chronic thrombo-embolic pulmonary hypertension (group 4)

10.1. Diagnosis

10.2. Therapy.

11. Pulmonary hypertension with unclear and/or multi-factorial mechanisms

(group 5)

12. Definition of a pulmonary hypertension centre

12.1. Facilities and skills required for a pulmonary hypertension centre

12.2. Patient associations and patient empowerment